Viatris Pre-Tax Profit Margin 2010-2024 | VTRS

Current and historical pre-tax profit margin for Viatris (VTRS) from 2010 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Viatris pre-tax profit margin for the three months ending September 30, 2024 was .
Viatris Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2024-09-30 $15.05B $-0.95B -6.32%
2024-06-30 $15.24B $-0.64B -4.20%
2024-03-31 $15.36B $0.09B 0.55%
2023-12-31 $15.43B $0.20B 1.32%
2023-09-30 $15.47B $2.53B 16.34%
2023-06-30 $15.60B $2.55B 16.36%
2023-03-31 $15.80B $2.61B 16.51%
2022-12-31 $16.26B $2.81B 17.30%
2022-09-30 $16.73B $1.14B 6.82%
2022-06-30 $17.19B $0.91B 5.31%
2022-03-31 $17.65B $0.31B 1.73%
2021-12-31 $17.89B $-0.66B -3.71%
2021-09-30 $17.17B $-1.47B -8.59%
2021-06-30 $15.60B $-1.43B -9.18%
2021-03-31 $13.76B $-1.19B -8.67%
2020-12-31 $11.95B $-0.72B -6.04%
2020-09-30 $11.51B $0.43B 3.72%
2020-06-30 $11.50B $0.37B 3.23%
2020-03-31 $11.63B $0.30B 2.58%
2019-12-31 $11.50B $0.15B 1.34%
2019-09-30 $11.39B $0.10B 0.84%
2019-06-30 $11.29B $0.10B 0.90%
2019-03-31 $11.25B $0.17B 1.54%
2018-12-31 $11.43B $0.30B 2.62%
2018-09-30 $11.59B $0.55B 4.74%
2018-06-30 $11.72B $0.54B 4.58%
2018-03-31 $11.87B $0.84B 7.10%
2017-12-31 $11.91B $0.90B 7.59%
2017-09-30 $11.94B $0.80B 6.72%
2017-06-30 $12.01B $0.30B 2.47%
2017-03-31 $11.61B $0.18B 1.51%
2016-12-31 $11.08B $0.12B 1.10%
2016-09-30 $10.30B $0.12B 1.12%
2016-06-30 $9.94B $0.90B 9.01%
2016-03-31 $9.75B $0.87B 8.95%
2015-12-31 $9.43B $0.92B 9.70%
2015-09-30 $9.02B $0.97B 10.74%
2015-06-30 $8.41B $0.93B 11.02%
2015-03-31 $7.88B $0.88B 11.22%
2014-12-31 $7.72B $0.98B 12.63%
2014-09-30 $7.45B $0.90B 12.03%
2014-06-30 $7.13B $0.68B 9.51%
2014-03-31 $6.99B $0.76B 10.87%
2013-12-31 $6.91B $0.75B 10.81%
2013-09-30 $6.82B $0.75B 10.92%
2013-06-30 $6.86B $0.82B 11.88%
2013-03-31 $6.85B $0.79B 11.47%
2012-12-31 $6.80B $0.80B 11.83%
2012-09-30 $6.61B $0.74B 11.23%
2012-06-30 $6.38B $0.67B 10.49%
2012-03-31 $6.27B $0.68B 10.89%
2011-12-31 $6.13B $0.66B 10.69%
2011-09-30 $6.03B $0.52B 8.69%
2011-06-30 $5.81B $0.46B 7.98%
2011-03-31 $5.61B $0.36B 6.46%
2010-12-31 $5.45B $0.36B 6.55%
2010-09-30 $5.37B $0.33B 6.20%
2010-06-30 $5.28B $0.19B 3.51%
2010-03-31 $5.18B $0.21B 3.98%
2009-12-31 $5.09B $0.23B 4.46%
Sector Industry Market Cap Revenue
Medical Medical Services $14.478B $15.427B
Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor and Viagra. Biosimilars portfolio include pegfilgrastim, trastuzumab and adalimumab biosimilars. It has obtained approval for the biosimilar of Avastin and Insulin Aspart in Europe. The company reports in following segments: Developed Markets, Greater China, JANZ & Emerging Markets. The Developed Markets segment comprises operations in N. America and Europe. The Greater China segment operates in China, Taiwan and Hong Kong. The JANZ segment will report for operations in Japan, Australia and New Zealand, while the Emerging Markets segment will include operations in Asia, the Middle East, South and Central America, Africa and E. Europe. This segment also includes the company's anti-retroviral franchise.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $84.995B 10.55
Cencora (COR) United States $43.734B 16.44
DiDi Global (DIDIY) China $22.941B 0.00
Natera (NTRA) United States $20.871B 0.00
ICON (ICLR) Ireland $16.879B 15.03
Avantor (AVTR) United States $14.307B 21.45
Revvity (RVTY) United States $13.453B 23.37
BioMerieux (BMXMF) France $12.659B 0.00
CochLear (CHEOY) Australia $11.807B 0.00
Solventum (SOLV) United States $11.540B 0.00
Medpace Holdings (MEDP) United States $10.417B 29.35
Doximity (DOCS) United States $10.302B 60.64
Charles River Laboratories (CRL) United States $9.314B 18.00
HealthEquity (HQY) United States $8.212B 41.20
Sonic Healthcare (SKHHY) Australia $8.208B 0.00
Bausch + Lomb (BLCO) Canada $6.322B 29.43
Amplifon S.p.A (AMFPF) Italy $5.864B 29.89
Sotera Health (SHC) United States $3.759B 20.11
Organon (OGN) United States $3.719B 3.75
BrightSpring Health Services (BTSG) United States $2.967B 63.11
Surgery Partners (SGRY) United States $2.493B 28.42
Concentras Parent (CON) United States $2.491B 0.00
Ardent Health Partners (ARDT) United States $2.291B 0.00
GeneDx Holdings (WGS) United States $2.069B 0.00
Premier (PINC) United States $2.067B 10.76
PACS (PACS) United States $1.992B 0.00
Alignment Healthcare (ALHC) United States $1.969B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.730B 0.00
GoodRx Holdings (GDRX) United States $1.711B 44.90
Teladoc Health (TDOC) United States $1.544B 0.00
Pediatrix Medical (MD) United States $1.224B 11.98
Progyny (PGNY) United States $1.208B 24.47
Embecta (EMBC) United States $1.161B 8.12
CareDx (CDNA) United States $1.102B 0.00
Establishment Labs Holdings (ESTA) $1.090B 0.00
AMN Healthcare Services Inc (AMN) United States $0.874B 5.91
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Agilon Health (AGL) United States $0.775B 0.00
SBC Medicals (SBC) United States $0.649B 0.00
Auna S.A (AUNA) Luxembourg $0.492B 0.00
InnovAge Holding (INNV) United States $0.478B 0.00
DocGo (DCGO) United States $0.444B 16.73
Sonida Senior Living (SNDA) United States $0.441B 0.00
Enhabit (EHAB) United States $0.387B 33.48
Sera Prognostics (SERA) United States $0.275B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.268B 0.00
LifeMD (LFMD) United States $0.212B 0.00
Biodesix (BDSX) United States $0.198B 0.00
Beauty Health (SKIN) United States $0.176B 0.00
Nutex Health (NUTX) United States $0.160B 0.00
ModivCare (MODV) United States $0.156B 8.44
MultiPlan (MPLN) United States $0.108B 0.00
Ascend Wellness Holdings (AAWH) United States $0.099B 0.00
So-Young (SY) China $0.093B 15.69
IceCure Medical (ICCM) Israel $0.052B 0.00
Singular Genomics Systems (OMIC) United States $0.050B 0.00
OncoCyte (OCX) United States $0.037B 0.00
NeueHealth (NEUE) United States $0.033B 0.87
Pheton Holdings (PTHL) China $0.027B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.023B 0.00
Co-Diagnostics (CODX) United States $0.023B 0.00
Oncology Institute (TOI) United States $0.016B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
KindlyMD (KDLY) United States $0.007B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
Cano Health (CANOQ) United States $0.001B 0.00
Aclarion (ACON) United States $0.001B 0.00